Catalyzing Discoveries | Revolutionizing Healthcare
Discovery
Transforming the discovery process with advanced technology, delivering innovative breakthroughs with precision and speed.
Development
Accelerating development through collaborative solutions, ensuring efficiency and accuracy at every critical stage.
Manufacture
Effortlessly evolving from research to full-scale production while maintaining rigorous quality controls at every stage.
Who We are
Aryastha Helps You
Scientific Expertise Team
Expert innovators in drug discovery, redefining therapeutic possibilities creatively.
Advanced Technology
Game-changing technology accelerates drug discovery, enabling faster, smarter decisions.
Trusted Partnership
Building lasting partnerships through trust, collaboration, and shared success.
World-Class Laboratory
State-of-the-art lab for precision research, turning scientific ideas into reality.
Latest Events & Updates
Diwali Celebrations
October 20, 2025
Drug Discovery & Development Workshop 2025
September 22, 2025
Ganesh Chaturthi Celebrations 2025
August 27, 2025
Celebrating our culture, people and values
March 28, 2025
Drug Discovery and Development Services
Aryastha Infrastructure
Comprehensive world-class facility in India
~20,000 SQFT of dedicated R&D center
A powerhouse of innovation, advancing research from discovery to impactful development.
24/7 Analytical & ancillary support
24/7 support at Aryastha ensures seamless progress with real-time research insights.
State of the art analytical instrumentation
Aryastha delivers precision and speed using advanced HPLC and NMR for timely, accurate analysis and purification.
Our services
What We Do
Aryastha’s services and alliances are built on a cutting-edge technology platform, offering a broad range of capabilities throughout the drug discovery process. With a strong track record, experienced scientists, and innovative technology, we provide comprehensive discovery services from target identification to preclinical candidate nomination. Our extensive expertise spans Chemistry, Biology, DMPK, and Pharmacology, supporting both stand-alone and integrated solutions.
Discovery Chemistry
Medicinal chemistry in drug discovery involves the intricate process of conceiving and developing new medicines. While this journey is lengthy, complex, expensive, and risky, the potential benefits for millions of patients with serious illnesses serve as a constant driving force.
Discovery Biology
Aryastha Life Sciences specializes in drug discovery and development services, harnessing the power of established cell line, primary cells from diseased organs, and in vivo models, including syngeneic and cell/tissue-derived systems.
Pre-Clinical DMPK
Aryastha provides a comprehensive range of services encompassing in vitro ADME, toxicity (in vitro ADMET), and in vivo pharmacokinetics (PK), offering rapid evaluations of test articles DMPK properties and toxicity.
Development Services
The journey of a drug substance through medicinal chemistry rarely concludes with an ultimate production route. Scaling a drug substance from milligrams to kilograms entails much more.
Co-Founders & Leadership
Aryastha Co-Founders & Leadership combine unmatched agility and flexibility, continuously driving innovation and scientific excellence to accelerate the delivery of life-changing medicines. Over the years, they have transformed Aryastha into a trusted, one-stop solution for the pharmaceutical and biotechnology industries by addressing critical challenges in drug discovery and development. With their extensive experience, they’ve successfully advanced 6 clinical assets through phases I, II, and III, secured 11 IND approvals, and led over 75 integrated programs.
IP & Confidentiality
IP owned by the client
Restricted role-based access control to ensure IP protection and confidentiality of client programs
Secured IT infrastructure with multi-factor authentication in place to protect against any cyber threats
Business Model & Scalability
Ability to quickly scale-up infrastructure and skilled manpower as per client requirement.
Flexible Business Models
Aryastha Life Sciences Blogs
𝐇𝐚𝐩𝐩𝐲 𝐓𝐡𝐚𝐧𝐤𝐬𝐠𝐢𝐯𝐢𝐧𝐠! 🧡
Heartfelt thanks to everyone who has supported us—your trust and encouragement mean everything.
Wishing you a joyful season filled with warmth, appreciation, and happiness.
Let’s continue to grow together with gratitude and positivity.
#AryasthaLifeSciences #HappyThanksgiving #Gratitude #ThankfulHeart #Thanksgiving2025 #ThanksgivingVibes #ThanksgivingSeason #ThankfulForYou #GratefulAlways #FestiveSeason #AppreciationPost
Aryastha showcased its innovative technology platform, 𝐁𝐢𝐨𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧®, at the 𝟐𝟎𝟐𝟓 𝐀𝐧𝐧𝐮𝐚𝐥 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 𝐟𝐨𝐫 𝐈𝐦𝐦𝐮𝐧𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐨𝐟 𝐂𝐚𝐧𝐜𝐞𝐫 (𝐒𝐈𝐓𝐂) in National Harbor, Maryland, USA. Chief of Aryastha’s Clinical team 𝐃𝐫. 𝐆𝐧𝐚𝐞𝐬𝐰𝐚𝐫 𝐀𝐭𝐭𝐮𝐫𝐮, 𝐌𝐃, 𝐅𝐑𝐂𝐏, delivered a podium presentation on the use of Patient Tumor-Derived Organoids to predict clinical outcomes and understand the mechanisms of action of targeted therapies and immune checkpoint inhibitors. Head of Biology, 𝐃𝐫. 𝐒𝐮𝐦𝐚𝐧 𝐃𝐮𝐭𝐭𝐚, 𝐏𝐡𝐃, also presented the BioSolution platform’s application in Integrated Drug Development (IDD) process to facilitate shorter time and better route for clinical success. His poster received high recognition, ranking 𝟏𝟓𝟎𝐭𝐡 𝐨𝐮𝐭 𝐨𝐟 𝟏,𝟑𝟓𝟎 𝐩𝐨𝐬𝐭𝐞𝐫𝐬 submitted at the event.
The sessions and booth attracted hundreds of scientists from the biotech, academic, and pharmaceutical sectors, all expressing strong interest in leveraging the BioSolution platform for their own drug development efforts.
𝐂𝐡𝐢𝐞𝐟 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐀𝐝𝐯𝐢𝐬𝐨𝐫 𝐃𝐫. 𝐏𝐫𝐚𝐝𝐢𝐩 𝐊 𝐌𝐚𝐣𝐮𝐦𝐝𝐞𝐫, 𝐏𝐡𝐃 and 𝐂𝐡𝐢𝐞𝐟 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐎𝐟𝐟𝐢𝐜𝐞𝐫 𝐃𝐫. 𝐑𝐚𝐠𝐡𝐚𝐯 𝐑𝐞𝐝𝐝𝐲 𝐊𝐞𝐭𝐡𝐢𝐫𝐢, 𝐏𝐡𝐃 have also joined the team for strategic discussion with biopharma partners.
🔗 www.aryastha.com
#AryasthaLifeSciences #SITC2025 #BioSolutionPlatform #DrugDiscovery #Immunotherapy #OncologyResearch #BiotechInnovation #ClinicalResearch #TranslationalOncology #PharmaInnovation #CancerResearch #Biopharma #LifeSciences #Biotech #FutureOfMedicine #MedicalInnovation #BioSolution #Organoids #TumorOrganoids #PrecisionOncology #Aryastha #ScientificInnovation
𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭 | 𝐀𝐫𝐲𝐚𝐬𝐭𝐡𝐚 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬
We are proud to welcome Dr. Salma Shirin as Senior Director, R&D Services at Aryastha Life Sciences.
With over two decades of global experience in preclinical drug discovery and development, Dr. Salma has held pivotal scientific and leadership roles at Praesidia Biotherapeutics (Boston, USA), Dalriada Drug Discovery (Toronto, Canada), Bimeda MTC Animal Health Inc. (Cambridge, ON), Exova (now Element, Mississauga, ON)
Her deep expertise and strategic vision will be instrumental in advancing our R&D capabilities and strengthening client partnerships.
We’re excited to have her on board and look forward to her contributions to Aryastha’s journey of scientific excellence.
🔗 www.aryastha.com
#Leadership #LifeSciences #DrugDiscovery #R_D #TeamAryastha #ScientificExcellence #AryasthaLifeSciences #Biotechnology #LeadershipAnnouncement #RAndDExcellence #PharmaInnovation #ScientificLeadership #GlobalExpertise
🌍𝐀𝐫𝐲𝐚𝐬𝐭𝐡𝐚 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟓 | 𝐀𝐦𝐬𝐭𝐞𝐫𝐝𝐚𝐦, 𝐍𝐞𝐭𝐡𝐞𝐫𝐥𝐚𝐧𝐝𝐬
We’re delighted to participate in the Drug Discovery Strategic Summit (DDSS) 2025, a platform that brings together global leaders in pharma and biotech to discuss the future of drug innovation. As a company committed to innovation and collaboration, Aryastha Life Sciences is proud to join global leaders, visionaries, and researchers in advancing the frontiers of drug discovery and development.
📅 19–20 November 2025
📍 Amsterdam, Netherlands (EU)
Meet our experts:
👨🔬 Dr. Raghava Reddy Kethiri, Ph.D – Chief Executive Officer
👨🔬 Dr. Kailash Pawar, Ph.D – Director, Techno Commercial Europe
Join us as we engage with pioneers, exchange insights, and explore breakthroughs shaping next-generation therapeutics.
📩 For collaboration opportunities, reach out at [email protected]
#AryasthaLifeSciences #DrugDiscovery #DDSS2025 #PharmaInnovation #BiotechLeaders #GlobalSummit #ResearchExcellence #LifeSciences #PharmaLeadership #DrugDevelopment #HealthcareInnovation #TranslationalResearch
